Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
Quest Diagnostics (NYSE: DGX), a diagnostic information services leader, has announced that Chairman, CEO and President Jim Davis will participate in the Baird 2025 Global Healthcare Conference. The presentation will take place on September 10, 2025, at 10:50 a.m. Eastern Time in New York City.
The event will feature a fireside chat and Q&A session focusing on Quest's strategy, performance, and market trends. Investors can access the live webcast through Quest's investor relations website at ir.QuestDiagnostics.com. The archived webcast will be available within 24 hours after the event and remain accessible until October 3, 2025.
Quest Diagnostics (NYSE: DGX), leader nei servizi di informazione diagnostica, ha annunciato che il Presidente, Amministratore Delegato e Presidente Jim Davis parteciperà alla Baird 2025 Global Healthcare Conference. La presentazione si terrà il 10 settembre 2025 alle 10:50, ora orientale a New York City.
L'evento prevedrà un dialogo informale e una sessione di domande e risposte incentrati sulla strategia, le performance e le tendenze di mercato di Quest. Gli investitori potranno seguire il webcast in diretta tramite il sito investor relations di Quest all'indirizzo ir.QuestDiagnostics.com. Il webcast archiviato sarà disponibile entro 24 ore dall'evento e resterà accessibile fino al 3 ottobre 2025.
Quest Diagnostics (NYSE: DGX), líder en servicios de información diagnóstica, ha anunciado que el Presidente, Director Ejecutivo y Presidente Jim Davis participará en la Baird 2025 Global Healthcare Conference. La presentación se realizará el 10 de septiembre de 2025 a las 10:50 a.m., hora del Este en la ciudad de Nueva York.
El evento incluirá una charla informal y una sesión de preguntas y respuestas centradas en la estrategia, el desempeño y las tendencias de mercado de Quest. Los inversores podrán acceder al webcast en vivo a través del sitio de relaciones con inversionistas de Quest en ir.QuestDiagnostics.com. El webcast archivado estará disponible dentro de las 24 horas siguientes al evento y permanecerá accesible hasta el 3 de octubre de 2025.
Quest Diagnostics (NYSE: DGX)는 진단 정보 서비스 선도 기업으로서 회장 겸 최고경영자(CEO) 겸 사장인 짐 데이비스(Jim Davis)가 Baird 2025 Global Healthcare Conference에 참석한다고 발표했습니다. 발표는 2025년 9월 10일 동부 표준시 오전 10시 50분에 뉴욕시에서 진행됩니다.
행사는 퀘스트의 전략, 실적 및 시장 동향을 중심으로 한 좌담 및 질의응답 세션으로 구성됩니다. 투자자들은 Quest의 IR 사이트 ir.QuestDiagnostics.com을 통해 라이브 웹캐스트에 접속할 수 있습니다. 기록된 웹캐스트는 행사 종료 후 24시간 이내에 제공되며 2025년 10월 3일까지 이용 가능합니다.
Quest Diagnostics (NYSE: DGX), leader des services d'information diagnostique, a annoncé que le président, directeur général et CEO Jim Davis participera à la Baird 2025 Global Healthcare Conference. La présentation aura lieu le 10 septembre 2025 à 10h50, heure de l'Est à New York.
L'événement comprendra une discussion informelle et une séance de questions-réponses axées sur la stratégie, les performances et les tendances du marché de Quest. Les investisseurs pourront accéder au webcast en direct via le site des relations investisseurs de Quest à ir.QuestDiagnostics.com. Le webcast archivé sera disponible dans les 24 heures suivant l'événement et restera accessible jusqu'au 3 octobre 2025.
Quest Diagnostics (NYSE: DGX), ein führender Anbieter von diagnostischen Informationsdiensten, hat bekannt gegeben, dass Chairman, CEO und President Jim Davis an der Baird 2025 Global Healthcare Conference teilnehmen wird. Die Präsentation findet am 10. September 2025 um 10:50 Uhr Eastern Time in New York City statt.
Die Veranstaltung umfasst ein Gespräch am Kamin und eine Frage-Antwort-Runde mit Schwerpunkt auf Quests Strategie, Leistung und Markttrends. Investoren können das Live-Webcast über die Investor-Relations-Website von Quest unter ir.QuestDiagnostics.com verfolgen. Das archivierte Webcast wird innerhalb von 24 Stunden nach der Veranstaltung verfügbar sein und bis zum 3. Oktober 2025 abrufbar bleiben.
- None.
- None.
The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 3, 2025.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2025-global-healthcare-conference-302531411.html
SOURCE Quest Diagnostics
FAQ
When is Quest Diagnostics (DGX) presenting at the Baird 2025 Global Healthcare Conference?
Who will represent Quest Diagnostics at the Baird 2025 Healthcare Conference?
How can investors access Quest Diagnostics' presentation at the Baird conference?
How long will Quest Diagnostics' Baird conference presentation be available online?
